Shanghai HeartCare Medical Technology Corporation Limited

SEHK:6609 Stock Report

Market Cap: HK$860.1m

Shanghai HeartCare Medical Technology Balance Sheet Health

Financial Health criteria checks 6/6

Shanghai HeartCare Medical Technology has a total shareholder equity of CN¥1.1B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥1.2B and CN¥125.8M respectively.

Key information

0%

Debt to equity ratio

CN¥0

Debt

Interest coverage ration/a
CashCN¥723.60m
EquityCN¥1.07b
Total liabilitiesCN¥125.76m
Total assetsCN¥1.20b

Recent financial health updates

Recent updates

Even With A 42% Surge, Cautious Investors Are Not Rewarding Shanghai HeartCare Medical Technology Corporation Limited's (HKG:6609) Performance Completely

Sep 27
Even With A 42% Surge, Cautious Investors Are Not Rewarding Shanghai HeartCare Medical Technology Corporation Limited's (HKG:6609) Performance Completely

Some Shareholders Feeling Restless Over Shanghai HeartCare Medical Technology Corporation Limited's (HKG:6609) P/S Ratio

Aug 01
Some Shareholders Feeling Restless Over Shanghai HeartCare Medical Technology Corporation Limited's (HKG:6609) P/S Ratio

We're Not Very Worried About Shanghai HeartCare Medical Technology's (HKG:6609) Cash Burn Rate

Jan 23
We're Not Very Worried About Shanghai HeartCare Medical Technology's (HKG:6609) Cash Burn Rate

Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609) Shares May Have Slumped 27% But Getting In Cheap Is Still Unlikely

Aug 30
Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609) Shares May Have Slumped 27% But Getting In Cheap Is Still Unlikely

Companies Like Shanghai HeartCare Medical Technology (HKG:6609) Are In A Position To Invest In Growth

Aug 09
Companies Like Shanghai HeartCare Medical Technology (HKG:6609) Are In A Position To Invest In Growth

Companies Like Shanghai HeartCare Medical Technology (HKG:6609) Are In A Position To Invest In Growth

May 07
Companies Like Shanghai HeartCare Medical Technology (HKG:6609) Are In A Position To Invest In Growth

We're Hopeful That Shanghai HeartCare Medical Technology (HKG:6609) Will Use Its Cash Wisely

Nov 29
We're Hopeful That Shanghai HeartCare Medical Technology (HKG:6609) Will Use Its Cash Wisely

Financial Position Analysis

Short Term Liabilities: 6609's short term assets (CN¥1.0B) exceed its short term liabilities (CN¥61.9M).

Long Term Liabilities: 6609's short term assets (CN¥1.0B) exceed its long term liabilities (CN¥63.8M).


Debt to Equity History and Analysis

Debt Level: 6609 is debt free.

Reducing Debt: 6609 had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable 6609 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: 6609 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 3% per year.


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 07:23
End of Day Share Price 2024/12/24 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shanghai HeartCare Medical Technology Corporation Limited is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jin ZhangChina International Capital Corporation Limited
Yuan GaoChina International Capital Corporation Limited
Chris PanGoldman Sachs